Advertisements



The Week Ahead In Biotech: Moderna Vaccine And Roche, Revance, Rhythm, Liquidia FDA Updates

Biotech stocks came under pressure in the week ended Nov. 20, reversing course from the previous week. read more.....»»

Category: blogSource: benzingaNov 22nd, 2020

The Week Ahead In Biotech: Moderna Vaccine And Roche, Revance, Rhythm, Liquidia FDA Updates

Biotech stocks came under pressure in the week ended Nov. 20, reversing course from the previous week. read more.....»»

Category: blogSource: benzingaNov 22nd, 2020

The Week Ahead In Biotech: The Vaccine Updates, Drug Presentations, And FDA Decisions That Will Move The Markets

Biotech stocks advanced in the week ended Nov. 13 amid a vaccine news flow-induced rally that also lifted the broader market. read more.....»»

Category: blogSource: benzingaNov 15th, 2020

The Week Ahead In Biotech: Kala FDA Decision, Merck & Pfizer Earnings, Vaccine Updates And IPOs

Biotech stocks posted weekly declines in the week ended Oct. 23, pressured by the broader market decline amid mixed earnings reports and the impasse on fiscal stimulus. After declining in the first three sessions of the week, the iShares.....»»

Category: earningsSource: benzingaOct 25th, 2020

The Week Ahead In Biotech: Kala FDA Decision, Merck & Pfizer Earnings, Vaccine Updates And IPOs

Biotech stocks posted weekly declines in the week ended Oct. 23, pressured by the broader market decline amid mixed earnings reports and the impasse on fiscal stimulus. read more.....»»

Category: blogSource: benzingaOct 25th, 2020

The Week Ahead In Biotech: FDA Decisions For Mesoblast And Eton, Coronavirus Vaccine Updates

Biotech stock reversed course last week, dragged lower by the broader market weakness. The week's news flow was headlined by Johnson & Johnson (NYSE: JNJ) kickstarting a Pha.....»»

Category: earningsSource: benzingaSep 27th, 2020

The Week Ahead In Biotech: FDA Decisions For Mesoblast And Eton, Coronavirus Vaccine Updates

Biotech stock reversed course last week, dragged lower by the broader market weakness. read more.....»»

Category: blogSource: benzingaSep 27th, 2020

The Week Ahead In Biotech: Conference Presentations, IPOs In The Mix

Biotech stocks found themselves among gains in the week ended Sept. 18, with conference presentations, IPO news flow and updates on coronavirus vaccine/antibody candidates catalyzing some strong moves. read more.....»»

Category: blogSource: benzingaSep 20th, 2020

The Week Ahead In Biotech: Bristol-Myers Squibb FDA Decision, Adcom Review For Glaxo, Amarin Vascepa Hearing

Biotech stocks went about a consolidation move in the week ended Aug. 28 amid thin news flow. Barring updates on coronavirus vaccine/treatment candidates, there was very little for the sector to react to. read more.....»»

Category: blogSource: benzingaAug 30th, 2020

The Week Ahead In Biotech (Aug. 30- Sept. 5): Bristol-Myers Squibb FDA Decision, Adcom Review For Glaxo, Amarin Vascepa Hearing

Biotech stocks went about a consolidation move in the week ended Aug. 28 amid thin news flow. Barring updates on coronavirus vaccine/treatment candidates, there was very little for the sector to react to. read more.....»»

Category: blogSource: benzingaAug 30th, 2020

The Daily Biotech Pulse: Pfizer Earnings, Roche"s Spinal Muscular Dystrophy Treatment, Moderna COVID-19 Vaccine Update

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) read more.....»»

Category: blogSource: benzingaApr 28th, 2020

AstraZeneca Vaccine Elicits "Strong Immune Response" In Older Adults, Final Moderna Results Due In A Week: Live Updates

AstraZeneca Vaccine Elicits "Strong Immune Response" In Older Adults, Final Moderna Results Due In A Week: Live Updates.....»»

Category: smallbizSource: nytNov 19th, 2020

CureVac"s Covid vaccine has one key advantage over Moderna, Pfizer

The German biotech with U.S. headquarters in Boston said this week that its candidate has one big advantage that could bypass an issue its rivals are facing......»»

Category: topSource: bizjournalsNov 12th, 2020

The Daily Biotech Pulse: FDA Vaccine Committee Meeting, Roche In $350M Deal for COVID-19 Treatment, Edwards Lifesciences Reports Q3 Beat

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct.....»»

Category: earningsSource: benzingaOct 22nd, 2020

The Daily Biotech Pulse: FDA Vaccine Committee Meeting, Roche In $350M Deal for COVID-19 Treatment, Edwards Lifesciences Reports Q3 Beat

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 21) read more.....»»

Category: blogSource: benzingaOct 22nd, 2020

The Week Ahead In Biotech: Bausch Health, Fennec Pharma FDA Decisions And Smid-cap Earnings

Biotech stocks advanced in the week ended Aug. 7, buoyed by multiple catalysts. Aside from the broader market strength, mostly positive earnings and continuing coronavirus treatment/vaccine news flow supported the move to the upside. read more.....»»

Category: blogSource: benzingaAug 9th, 2020

The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings

Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts. read more.....»»

Category: blogSource: benzingaAug 2nd, 2020

The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings

Bio.....»»

Category: earningsSource: benzingaAug 2nd, 2020

The Daily Biotech Pulse: Gilead Slips Despite Forecast-Beating Q1, Moderna Partners With Lonza For Coronavirus Vaccine Production, Lyra Therapeutics IPO

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs May 1.) read more.....»»

Category: blogSource: benzingaMay 1st, 2020

The Daily Biotech Pulse: Pfizer Earnings, Roche"s Spinal Muscular Dystrophy Treatment, Moderna COVID-19 Vaccine Update

Here's .....»»

Category: earningsSource: benzingaApr 28th, 2020

The Week Ahead In Biotech: Urogen FDA Decision, Amarin, J&J Earnings And More COVID-19 Updates

Biotech stocks moved higher last week along with the broader market. The week witnessed a few clinical readouts and pre-announcements that reflected the coronavirus (COVID-19) impact. read more.....»»

Category: blogSource: benzingaApr 12th, 2020